Compound ID | 200
Class: Antivirulence agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Staphylococcal toxic shock syndrome (TSS); aptamer antagonist of staphylococcal enterotoxin B |
| Institute where first reported: | Institute of Laboratory Medicine, Fuzhou General Hospital of Nanjing Military Command, Fuzhou, People's Republic of China |
| Year first mentioned: | 2015 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Citations: |
|